Barclays’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $412M | Sell |
|
|||||
|
2025
Q2 | $431M | Buy |
|
|||||
|
2025
Q1 | $511M | Buy |
|
|||||
|
2024
Q4 | $262M | Sell |
|
|||||
|
2024
Q3 | $353M | Sell |
|
|||||
|
2024
Q2 | $296M | Buy |
|
|||||
|
2024
Q1 | $331M | Sell |
|
|||||
|
2023
Q4 | $351M | Buy |
|
|||||
|
2023
Q3 | $317M | Sell |
|
|||||
|
2023
Q2 | $394M | Buy |
|
|||||
|
2023
Q1 | $281M | Sell |
|
|||||
|
2022
Q4 | $331M | Buy |
|
|||||
|
2022
Q3 | $280M | Buy |
|
|||||
|
2022
Q2 | $294M | Sell |
|
|||||
|
2022
Q1 | $367M | Sell |
|
|||||
|
2021
Q4 | $453M | Buy |
|
|||||
|
2021
Q3 | $415M | Buy |
|
|||||
|
2021
Q2 | $312M | Buy |
|
|||||
|
2021
Q1 | $253M | Buy |
|
|||||
|
2020
Q4 | $195M | Buy |
|
|||||
|
2020
Q3 | $177M | Buy |
|
|||||
|
2020
Q2 | $153M | Buy |
|
|||||
|
2020
Q1 | $131M | Sell |
|
|||||
|
2019
Q4 | $324M | Buy |
|
|||||
|
2019
Q3 | $180M | Sell |
|
|||||
|
2019
Q2 | $170M | Sell |
|
|||||
|
2019
Q1 | $183M | Buy |
|
|||||
|
2018
Q4 | $129M | Sell |
|
|||||
|
2018
Q3 | $188M | Sell |
|
|||||
|
2018
Q2 | $359M | Buy |
|
|||||
|
2018
Q1 | $249M | Buy |
|
|||||
|
2017
Q4 | $164M | Buy |
|
|||||
|
2017
Q3 | $121M | Buy |
|
|||||
|
2017
Q2 | $98.8M | Buy |
|
|||||
|
2017
Q1 | $81.2M | Buy |
|
|||||
|
2016
Q4 | $77M | Sell |
|
|||||
|
2016
Q3 | $72.6M | Buy |
|
|||||
|
2016
Q2 | $67.4M | Buy |
|
|||||
|
2016
Q1 | $39.4M | Sell |
|
|||||
|
2015
Q4 | $47.3M | Sell |
|
|||||
|
2015
Q3 | $99.4M | Buy |
|
|||||
|
2015
Q2 | $107M | Sell |
|
|||||
|
2015
Q1 | $130M | Sell |
|
|||||
|
2014
Q4 | $153M | Sell |
|
|||||
|
2014
Q3 | $146M | Buy |
|
|||||
|
2014
Q2 | $136M | Sell |
|
|||||
|
2014
Q1 | $177M | Buy |
|
|||||
|
2013
Q4 | $177M | Buy |
|
|||||
|
2013
Q3 | $96.9M | Buy |
|
|||||
|
2013
Q2 | $88.8M | Buy |
|